AZD-9684 Uses, Dosage, Side Effects and more
AZD-9684 is the first member of a new anti-thrombotic class (CPU inhibitors). It is being developed by AstraZeneca.
AZD-9684 enhances endogenous fibrinolysis.
| Attribute | Details |
|---|---|
| Trade Name | AZD-9684 |
| Generic | AZD-9684 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in thrombosis.
How AZD-9684 works
AZD-9684 is a Carboxypeptidase U inhibitor (CPUi).
